ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · IEX Real-Time Price · USD
6.15
-0.46 (-6.96%)
At close: Jul 19, 2024, 4:00 PM
6.22
+0.07 (1.14%)
Pre-market: Jul 22, 2024, 7:18 AM EDT

ALX Oncology Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Revenue
00001.184.8
Upgrade
Revenue Growth (YoY)
-----75.35%132.03%
Upgrade
Cost of Revenue
00001.084.36
Upgrade
Gross Profit
00000.110.44
Upgrade
Selling, General & Admin
27.0928.4829.0423.3914.813.31
Upgrade
Research & Development
148.75141.898.460.1728.9616.31
Upgrade
Operating Expenses
175.84170.28127.4483.5643.7719.62
Upgrade
Operating Income
-175.84-170.28-127.44-83.56-43.66-19.18
Upgrade
Interest Expense / Income
1.611.570.240.0100.02
Upgrade
Other Expense / Income
-11.24-11.04-4.26-0.081.840.01
Upgrade
Pretax Income
-166.2-160.81-123.42-83.48-45.5-19.21
Upgrade
Income Tax
000.06-0.020.240.03
Upgrade
Net Income
-166.2-160.81-123.48-83.46-45.74-19.24
Upgrade
Preferred Dividends
00005.24.03
Upgrade
Net Income Common
-166.2-160.81-123.48-83.46-50.94-23.27
Upgrade
Shares Outstanding (Basic)
50434140183
Upgrade
Shares Outstanding (Diluted)
50434140183
Upgrade
Shares Change
22.66%5.62%0.97%118.05%500.86%11.84%
Upgrade
EPS (Basic)
-3.71-3.74-3.03-2.07-2.76-7.56
Upgrade
EPS (Diluted)
-3.71-3.74-3.03-2.07-2.76-7.56
Upgrade
Free Cash Flow
-141.2-131.64-90.65-68.77-38.32-14.6
Upgrade
Free Cash Flow Per Share
-2.82-3.06-2.23-1.71-2.07-4.75
Upgrade
Gross Margin
----9.05%9.09%
Upgrade
Operating Margin
-----3693.99%-399.98%
Upgrade
Profit Margin
-----4309.81%-485.22%
Upgrade
Free Cash Flow Margin
-----3241.96%-304.46%
Upgrade
EBITDA
-163.76-158.4-122.84-83.42-45.3-18.76
Upgrade
EBITDA Margin
-----3832.23%-391.14%
Upgrade
Depreciation & Amortization
0.840.840.340.050.20.43
Upgrade
EBIT
-164.6-159.24-123.18-83.47-45.5-19.19
Upgrade
EBIT Margin
-----3849.32%-400.08%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).